On a consolidated basis, Larsen & Toubro (L&T)'s net profit fell 27.11% to Rs 2070 crore in Q4 March 2015 on the higher base net profit of Rs 2840 crore in Q4 March 2014, which included a one-time write back. The consolidated gross revenue rose 3.8% to Rs 28275 crore in Q4 March 2015 over Q4 March 2014, registering a modest growth as certain sectoral constraints slowed down the pace of execution. The result was announced on Saturday, 30 May 2015.
On a consolidated basis, L&T's net profit fell 2.79% to Rs 4765 crore in the year ended March 2015 over the year ended March 2014, mainly due to challenges faced during execution of international projects in the hydrocarbon sector. Infrastructure and Services businesses of the group, however, recorded healthy increase in the PAT, thereby limiting year on year (y-o-y) decline in overall net profit for the year at 2.8%. Moreover, net profit of the previous year included a one-time write back of Rs 664 crore on account of amortization charge of toll road projects. Neutralizing this high base effect, the net profit for the year ended March 2015 shows an increase.
L&T said it was successful in garnering fresh orders worth Rs 155367 crore at consolidated level during the year ended March 2015, recording an impressive y-o-y growth of 22%. The order inflow growth was driven by domestic orders across businesses. The International orders during the year at Rs 39116 crore constituted lower share at 25% of the order inflow, as the company was selective in pursuing international opportunities. The company said that 55% of the total order inflow during the year was secured by the Infrastructure segment.
The order intake for Q4 March 2015 was also higher at Rs 47582 crore recording a y-o-y growth of 39%. International order inflow during the quarter was at Rs 11364 crore constituted 24% of the order inflow for the quarter.
Consolidated order book of the group stood at Rs 232649 crore as at 31 March 2015, higher by 28% on a y-o-y basis. International order book constituted 26% of the total order book.
In its outlook, L&T said that subdued investment climate during the year 2014-15 limited opportunities for capital goods and infrastructure sector in India. Initiatives which could potentially trigger investment interest in core sectors were time consuming. The government is expected to address the policy hurdles by accelerating decision making and by enhancing the ease of doing business.
Meanwhile, the global recovery has been slow. Sharp decline in oil prices and persisting geo-political uncertainties in the Middle East Region have impacted the investment momentum. Several currencies have depreciated against the the US dollar causing changes in the competitive landscape, L&T added.
Though demand in short-term remains impacted, the reform process in India is expected to gain ground in the medium term. Faster implementation of crucial projects and de-bottlenecking of stalled projects will help revive the growth momentum. The Government's focus on infrastructure development, manufacturing of defence equipment, fast tracking power and mining sector reforms and providing thrust to Make in India programme are positive indicators for the company. Further, progress on major reforms like land acquisition and GST should significantly improve the sentiment, L&T said.
The company is well placed to benefit early as sustainable growth opportunities emerge over the next few years, L&T added.
On a consolidated basis, Cipla's net profit fell 0.4% to Rs 259.66 crore on 20.8% rise in total income to Rs 3153.89 crore in Q4 March 2015 over Q4 March 2014. Cipla said that the current year figures included the relevant results of the company's subsidiaries from the date they became subsidiary of the company and therefore the corresponding figures for the previous period are not comparable. The result was announced after market hours on Friday, 29 May 2015.
Cipla's earnings before interest, taxation, depreciation and amortization (EBITDA) grew by 24% to Rs 508 crore in Q4 March 2015 over Q4 March 2014.
Cipla's domestic sales grew by 20.7% to Rs 1086 crore in Q4 March 2015 over Q4 March 2014 largely on account of growth in Respiratory, Anti-infectives, Cardiac and Gastro Intestinal therapies.
Cipla's exports of formulations increased by 29.7% to Rs 1690 crore in Q4 March 2015 over Q4 March 2014. Exports of Active Pharmaceutical Ingredients (APIs) declined 14.58% to Rs 205 crore in Q4 March 2015 over Q4 March 2014.
On a consolidated basis, Sun Pharmaceutical Industries' net profit fell 44% to Rs 888.05 crore on 53.8% surge in total income to Rs 6540.74 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
Sun Pharmaceutical Industries said that the financials for Q4 March 2015 include the impact of the merger of the erstwhile Ranbaxy Laboratories into the company, and hence are not strictly comparable.
Sun Pharmaceutical Industries' EBITDA stood at Rs 880 crore resulting in EBITDA margin of 14.3% in Q4 March 2015. EBITDA as well as net profit were adversely impacted by a few items, relating to professional charges, harmonization of policies of erstwhile Ranbaxy with the company, etc, Sun Pharmaceutical Industries said. The impact of these items appearing above EBITDA was approximately 10% of net sales and on items appearing below EBITDA was approximately 7% of net sales, the company said.
Sales of branded prescription formulations in India was Rs 1569 crore in Q4 March 2015. Sales in the US were $488 million in Q4 March 2015. Sales in emerging markets were $123 million for Q4 March 2015. Formulation sales in Rest of World (ROW) markets excluding US and Emerging Markets were $84 million in Q4 March 2015.
Dilip Shanghvi, Managing Director of Sun Pharmaceutical Industries' said that post the completion of the merger, the company has commenced the integration of Ranbaxy. The company's performance was impacted due to various one-time charges, mainly on account of the Ranbaxy merger as well as due to price erosion for some products in the US. It also reflected the impact of supply constraints related to the on-going remediation efforts at some of the company's facilities, Dilip Shanghvi said. The company is pledged to being 100% cGMP compliant and is fully responsible towards customers and patients across the world for quality products, he added.
Shares of Hero MotoCorp turn ex-dividend today, 1 June 2015 for final dividend of Rs 30 per share for the year ended 31 March 2015.
Bharat Petroleum Corporation (BPCL) acquired 1.99 crore shares of Petronet CCK (PCCKL) (constituting 19.97% of the paid up capital of PCCKL) from a financial investor of PCCKL. With this acquisition, PCCKL is now a subsidiary of BPCL with BPCL holding 68.97%. PCCKL own and operates petroleum product pipeline from Kochi to Karur via Coimbatore for transportation of petroleum products.
On a consolidated basis, Reliance Capital's net profit rose 52.4% to Rs 407 crore on 36.7% rise in total income to Rs 2527 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
On a consolidated basis, Reliance Communications' net profit rose 46.2% to Rs 228 crore on 0.6% rise in total income to Rs 5703 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
Power Grid Corporation of India's net profit rose 20.1% to Rs 1412.48 crore on 17.4% rise in total income to Rs 4909.56 crore in Q4 March 2015 over Q4 March 2014. The result was announced on Saturday, 30 May 2015.
National Aluminium Company's net profit rose 105.8% to Rs 354.87 crore on 7% rise in total income to Rs 2111.73 crore in Q4 March 2015 over Q4 March 2014. The result was announced on Saturday, 30 May 2015.
On a consolidated basis, IRB Infrastructure Developers net profit rose 26.5% to Rs 138.22 crore on 11% rise in total income to Rs 1018.79 crore in Q4 March 2015 over Q4 March 2014.
Sun TV Network's net profit rose 2.7% to Rs 202.99 crore on 7.3% rise in total income to Rs 572.02 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
NHPC reported net profit of Rs 644.51 crore in Q4 March 2015, compared with net loss of Rs 707.40 crore in Q4 March 2014. Total income rose 22.3% to Rs 2175.34 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
Neyveli Lignite Corporation's net profit rose 36.9% to Rs 676.81 crore on 13.7% rise in total income to Rs 2204.45 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
On a consolidated basis, Glenmark Pharmaceuticals' net profit fell 75.4% to Rs 10.61 crore on 5% rise in total income to Rs 1776.14 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
On a consolidated basis, Suzlon Energy reported net loss of Rs 1212.06 crore in Q4 March 2015, higher than net loss of Rs 603.45 crore in Q4 March 2014. Total income fell 26.4% to Rs 4945.30 crore in Q4 March 2015 over Q4 March 2014. The result was announced after market hours on Friday, 29 May 2015.
Powered by Capital Market - Live News
